The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing existing literature without systematic search or meta-analytic pooling.
PubMed 39753766 · doi:10.1007/s40263-024-01148-2
What was done
This narrative review synthesized literature examining the relationship between cannabis use and psychiatric conditions, including mood disorders, anxiety, psychosis, and post-traumatic stress disorder (PTSD). It evaluated how outcomes are modulated by cannabis use patterns (frequency, dosage, cannabinoid profile such as delta-9-THC versus CBD, product type, and route of administration) and individual characteristics (age, sex, and genetic or family history).
What was found
The abstract reports no quantitative data or effect sizes. It qualitatively reports that negative clinical outcomes are predominantly associated with delta-9-THC exposure, whereas non-intoxicating cannabinoids such as CBD show therapeutic promise. Furthermore, youth and individuals with a family history or genetic liability for psychiatric disorders exhibit an elevated risk for negative outcomes.
Why it matters
Broad generalizations about cannabis and mental health overlook critical determinants of risk, including specific cannabinoid content and patient-level vulnerability. Identifying these moderating factors helps clinicians evaluate potential benefits versus psychiatric risks across distinct patient populations.
Limits
The paper is a narrative overview rather than a systematic review or meta-analysis, introducing risk of selection bias. The abstract provides no quantitative metrics or sample sizes. The authors note that the specific effects of biological sex and older age remain poorly understood and require further investigation.